Detalhe da pesquisa
1.
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
Ann Hematol
; 103(2): 427-436, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012435
2.
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML.
Cancer
; 129(17): 2637-2644, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37354090
3.
Oral anti-viral therapy for early COVID-19 infection in patients with haematological malignancies: A multicentre prospective cohort.
Br J Haematol
; 202(5): 928-936, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37259629
4.
TNFRSF13B gene mutation in familial acute myeloid leukemia: A new piece in the complex scenario of hereditary predisposition?
Hematol Oncol
; 41(5): 942-946, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534633
5.
IRF4 Gene Expression on the Trail of Molecular Response: Looking at Chronic Myeloid Leukemia from Another Perspective.
Acta Haematol
; 146(1): 37-43, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36195064
6.
COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report.
Br J Haematol
; 196(3): 559-565, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636033
7.
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study.
Blood
; 135(8): 534-541, 2020 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31877211
8.
Bosutinib in the real-life treatment of chronic myeloid leukemia patients aged >65 years resistant/intolerant to previous tyrosine-kinase inhibitors.
Hematol Oncol
; 39(3): 401-408, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33617659
9.
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib.
Ann Hematol
; 100(8): 2005-2014, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33388860
10.
The multi-tyrosine kinase inhibitor ponatinib for chronic myeloid leukemia: Real-world data.
Eur J Haematol
; 105(1): 3-15, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32145037
11.
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart.
Hematol Oncol
; 37(3): 296-302, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30892724
12.
Serological response following BNT162b2 anti-SARS-CoV-2 mRNA vaccination in haematopoietic stem cell transplantation patients.
Br J Haematol
; 196(4): 928-931, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34664267
13.
Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and "booster" dose.
Haematologica
; 107(5): 1218, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045696
14.
An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia.
Blood
; 118(15): 4079-85, 2011 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-21772050
15.
6q deletion detected by fluorescence in situ hybridization using bacterial artificial chromosome in chronic lymphocytic leukemia.
Eur J Haematol
; 91(1): 10-9, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23560441
16.
Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event.
Leuk Res
; 127: 107023, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36822077
17.
Efficacy of Remdesivir and Neutralizing Monoclonal Antibodies in Monotherapy or Combination Therapy in Reducing the Risk of Disease Progression in Elderly or Immunocompromised Hosts Hospitalized for COVID-19: A Single Center Retrospective Study.
Viruses
; 15(5)2023 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243285
18.
Plerixafor added to chemotherapy plus G-CSF is safe and allows adequate PBSC collection in predicted poor mobilizer patients with multiple myeloma or lymphoma.
Biol Blood Marrow Transplant
; 18(2): 241-9, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21791194
19.
Pure red aplasia induced by sodium valproate in a patient with Behçet's syndrome.
Clin Exp Rheumatol
; 35 Suppl 108(6): 132, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29148419
20.
The genomic analysis brings a new piece to the molecular jigsaw of idiopathic erythrocytosis.
Exp Hematol Oncol
; 11(1): 47, 2022 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36031623